evans blue has been researched along with Diabetic Retinopathy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bucolo, C; Dionysopoulou, S; Georgakis, S; Mastrodimou, N; Micale, V; Romano, GL; Spyridakos, D; Svensson, R; Thermos, K; Verginis, P; Walum, E; Wikstrom, P | 1 |
| Alves, MRP; Ambrósio, AF; Baptista, FI; Boia, R; Campos, EJ; Madeira, MH; Martins, J; Nunes, S; Pereira, FC; Reis, F; Santiago, AR | 1 |
| Astley, RA; Callegan, MC; Coburn, PS; Elliott, MH; LaGrow, AL; Miller, FC; Wiskur, BJ | 1 |
| Li, CP; Liu, B; Liu, XM; Song, SG; Wang, WQ | 1 |
| Arnold, E; Clapp, C; Colosi, P; Díaz-Lezama, N; Jeziorski, MC; Martínez de la Escalera, G; Moreno-Carranza, B; Ramírez, M; Wu, Z | 1 |
| Dosso, AA; Rungger-Brändle, E | 1 |
| Battistini, B; Gabra, BH; Lawson, SR; Nantel, F; Sirois, P | 1 |
| Chang, YH; Chen, CH; Chen, JT; Chen, PL; Lu, DW; Tai, MC | 1 |
| Clarke, KG; Gil, DW; Kusari, J; Padillo, E; Zhou, S | 1 |
| Almulki, L; Frimmel, S; Gragoudas, ES; Hafezi-Moghadam, A; Kim, IK; Miller, JW; Nakazawa, T; Noda, K; Skondra, D; Tayyari, F; Thomas, KL; Zandi, S | 1 |
| Dai, W; Ji, F; Jin, Y; Li, W; Lu, L; Luo, Y; Sinclair, SH; Wu, Y; Xu, G; Xu, GT; Yanoff, M; Zhang, J | 1 |
| Adamis, AP; Clemens, MW; Hassessian, H; Joussen, AM; Miyamoto, K; Qaum, T; Qin, W; Rudge, J; Wiegand, SJ; Xu, Q; Yancopoulos, GD | 1 |
12 other study(ies) available for evans blue and Diabetic Retinopathy
| Article | Year |
|---|---|
Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.
Topics: Animals; Cytokines; Diabetes Mellitus; Diabetic Retinopathy; Evans Blue; NADPH Oxidase 4; NADPH Oxidases; Rats; Retina; Streptozocin; Vascular Endothelial Growth Factor A | 2023 |
Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Carrier Proteins; Diabetic Retinopathy; Disease Models, Animal; Ependymoglial Cells; Evans Blue; Gene Expression Regulation; Interleukin-1beta; Male; Nitric Oxide Synthase Type II; Prediabetic State; Rats; Rats, Wistar; Receptors, GABA-A; Signal Transduction; Sucrose; Tight Junctions; Tomography, Optical Coherence; Transcription Factor Brn-3A; Tumor Necrosis Factor-alpha | 2018 |
Bloodstream-To-Eye Infections Are Facilitated by Outer Blood-Retinal Barrier Dysfunction.
Topics: Angiography; Animals; Blood-Retinal Barrier; Cell Survival; Cells, Cultured; Coloring Agents; Dextrans; Diabetic Retinopathy; Endophthalmitis; Evans Blue; Eye Infections, Bacterial; Fluorescein-5-isothiocyanate; Humans; Immunohistochemistry; Iodates; Klebsiella pneumoniae; Male; Mice; Mice, Inbred C57BL; Retinal Pigment Epithelium; Retinal Vessels; Staphylococcus aureus | 2016 |
Lignans Extracted from Eucommia Ulmoides Oliv. Protects Against AGEs-Induced Retinal Endothelial Cell Injury.
Topics: Animals; Blood-Retinal Barrier; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Eucommiaceae; Evans Blue; Gene Expression Regulation; Glycation End Products, Advanced; Heme Oxygenase-1; Hyperglycemia; Lignans; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Plant Extracts; Plant Leaves; Reactive Oxygen Species; Retina; Signal Transduction; Streptozocin | 2016 |
Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability.
Topics: Albumins; Animals; Capillary Permeability; Cell Cycle Proteins; Coloring Agents; Dependovirus; Dextrans; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Evans Blue; Fluorescein-5-isothiocyanate; Gene Transfer Techniques; Genetic Therapy; Green Fluorescent Proteins; HEK293 Cells; Humans; Intravitreal Injections; Male; Plasmids; Rats; Rats, Wistar; Retinal Hemorrhage; Vascular Endothelial Growth Factor A | 2011 |
Streptozotocin-induced diabetes--a rat model to study involvement of retinal cell types in the onset of diabetic retinopathy.
Topics: Animals; Capillary Permeability; Coloring Agents; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Evans Blue; Glycogen; Neurotransmitter Agents; Rats; Rats, Long-Evans; Retina; Retinal Vessels | 2003 |
Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
Topics: Animals; Blood Glucose; Bradykinin; Bradykinin B1 Receptor Antagonists; Capillary Permeability; Cardiomyopathies; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diabetic Retinopathy; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Insulin; Male; Rats; Rats, Wistar; Receptor, Bradykinin B1; Renal Insufficiency; Time Factors; Tissue Distribution; Triglycerides; Vascular Diseases | 2005 |
Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Evans Blue; Fluorescein-5-isothiocyanate; Hyperbaric Oxygenation; Male; Microscopy, Fluorescence; Rats; Rats, Sprague-Dawley; Retinal Vessels; Serum Albumin, Bovine | 2006 |
Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Blood-Retinal Barrier; Body Weight; Cell Count; Coloring Agents; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Electroretinography; Evans Blue; Excitatory Amino Acid Antagonists; Male; Memantine; Optic Nerve Diseases; Rats; Rats, Inbred BN; Retina; Retinal Ganglion Cells; Retinal Vessels; Streptozocin; Vascular Endothelial Growth Factor A; Vitreous Body | 2007 |
Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Topics: Animals; Antimicrobial Cationic Peptides; Aprotinin; Blood Proteins; Blood-Retinal Barrier; Capillary Permeability; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Evans Blue; Male; Monocyte Chemoattractant Proteins; Rats; Rats, Inbred BN; Rats, Long-Evans; Retinal Vessels; Serine Proteinase Inhibitors; Vascular Endothelial Growth Factor A | 2008 |
Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
Topics: Animals; Apoptosis; Blood-Retinal Barrier; Blotting, Western; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Erythropoietin; Evans Blue; Immunoenzyme Techniques; In Situ Nick-End Labeling; Injections; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Erythropoietin; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; STAT5 Transcription Factor; Vitreous Body | 2008 |
VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Topics: Animals; Blood-Retinal Barrier; Capillary Permeability; Coloring Agents; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Evans Blue; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |